Comparison of the Ulcerative Colitis Disease Activity Index between the... | Download Table
Epidermal Growth Factor Enemas with Oral Mesalamine for Mild-to-Moderate Left-Sided Ulcerative Colitis or Proctitis | NEJM
Modifi ed Mayo Disease Activity Index (MMDAI) a | Download Table
Identification of useful genes from multiple microarrays for ulcerative colitis diagnosis based on machine learning methods | Scientific Reports
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild‐to‐moderate ulcerative colitis - Danese - 2019 - United European Gastroenterology Journal - Wiley Online Library
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study - Gastroenterology
Inflammatory Bowel Disease | Clinical Gate
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis
Use of the ulcerative colitis endoscopic index of severity and Mayo endoscopic score for predicting the therapeutic effect of mesalazine in patients with ulcerative colitis - ScienceDirect
Modifi ed Mayo Disease Activity Index (MMDAI) a | Download Table
CDAI calculator (Crohn's Disease Activity Index)
The Efficacy of the Consumption of n-3 Polyunsaturated Fatty Acids for the Maintenance of Remission in Patients with Inflammatory Bowel Disease
Cochrane
Summary of activity indices used for ulcerative colitis | Download Table
Scores on Harvey Bradshaw Index (HB) and Ulcerative Colitis Disease... | Download Scientific Diagram
The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis - Clinical Gastroenterology and Hepatology
Guidelines for the management of ulcerative colitis in the adult population (update)
WO2014096873A1 - Biomarkers in inflammatory bowel disease - Google Patents
UC-Disease Activity Index | Download Table
Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis - Ma - 2018 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus - Vuitton - 2017 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study
Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts - The American Journal of Pathology
Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set - Clinical Gastroenterology and Hepatology
Metabolites | Free Full-Text | Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis | HTML
New approaches in the follow-up of patients suffering from inflammatory bowel diseases
